Skip to main content
Repurposing mebendazole against triple-negative breast cancer CNS metastasis.
Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience.
Combined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas.
Survival after chemotherapy and stem cell transplant followed by delayed craniospinal irradiation is comparable to upfront craniospinal irradiation in pediatric embryonal brain tumor patients.
Erratum to: Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma.
Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma.
Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study.
Pure germinomas of the central nervous system: treatment strategies and outcomes.
Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment.
Pilot study of systemic and intrathecal mafosfamide followed by conformal radiation for infants with intracranial central nervous system tumors: a pediatric brain tumor consortium study (PBTC-001).